High Risk MDS Treatment Strategies | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

High Risk MDS Treatment Strategies

Myelodysplastic Syndromes (MDS)
Presentation Date: 
Wed, 06/03/2020 - 8:00pm (EDT)

Michael Keng, M.D. is an Assistant Professor and holds a clinical faculty appointment in Medicine in the Division of Hematology/Oncology at UVA Cancer Center. He practices at the Emily Couric Clinical Cancer Center in Charlottesville and serves as an inpatient hematologist at UVA Hospital. His clinical areas of interest are: myelodysplastic syndromes, myeloproliferative disorders, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoid leukemia, and aplastic anemia. Dr. Keng provides a overview of the current treatment strategies for high risk MDS (myelodysplastic syndromes) patients and answers patient questions at the end of the presentation. Please note that this presentation is runs longer than most AAMDSIF webinars (1 hour, 27 minutes).